This program is independent and is not part of the official AAD Annual Meeting, as planned by its Scientific Assembly Committee
This program does not qualify for continuing medical education (CME) credit.
Sunday, March 19, 2023
6:45 – 7:00 PM CT: Registration and Dinner
7:00 – 9:00 PM CT: Symposium
Hilton Riverside New Orleans
Grand Ballroom D
Two Poydras St
New Orleans, LA 70130
FACULTY
Peter A. Lio, MD
Clinical Assistant Professor of Dermatology and Pediatrics
Northwestern University
Feinberg School of Medicine
Chicago,IL
Robert Sidbury, MD, MPH
Professor, Department of Pediatrics
University of Washington School of Medicine
Chief, Division of Dermatology
Seattle Children’s Hospital
Seattle, WA
PROGRAM DESCRIPTION
This innovative and engaging symposium is an animated simulation challenge, which will assist Healthcare providers to utilize assessment tools to evaluate disease burden and severity; compare and contrast systemic treatment options for the management of moderate-to-severe atopic dermatitis (AD); and develop proactive treatment plans that manage signs and symptoms, minimize disease flares, and improve quality of life in pediatric and adult patients with AD.
TARGET AUDIENCE
This educational activity is intended for dermatologists, pediatric dermatologists, allergists, and other healthcare professionals involved in the management of pediatric and adult patients with moderate-to-severe AD.
LEARNING OBJECTIVES
- Utilize assessment tools to evaluate disease burden and severity
- Compare and contrast systemic treatment options for the management of moderate-to-severe AD
- Develop proactive treatment plans that manage signs and symptoms, minimize disease flares and improve quality of life in pediatric and adult patients with AD
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education ACCME Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During the course of this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
DISCLAIMER
Med Learning Group makes every effort to develop activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.
For questions, please contact Med Learning Group at [email protected]
Contact this provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/
